Advertisements for pharmaceuticals may promote placebo responses by generating an expectation of therapeutic success. Some cite this as reason to favour Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA). Against this, I show placebo responses to emanate from beliefs rendered unjustified by the influence of a conditioning process. I argue that drug safety and efficacy are material properties and that unjustified beliefs in these domains entail costs to autonomy that outweigh any prudential gains attending a placebo response. I conclude that its placebogenic potential ought not to count as reason to favour DTCA.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Ader, R. (2003). Conditioned immunomodulation: Research needs and directions. Brain, Behavior, and Immunity, 17(Suppl 1), S51–S57.
Almasi, E. A., Stafford, R. S., Kravitz, R. L., & Mansfield, P. R. (2006). What are the public health effects of direct-to-consumer drug advertising? PLoS Medicine, 3(3), e145.
Amanzio, M., & Benedetti, F. (1999). Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems. Journal of Neuroscience, 19(1), 484–494.
Amgen Wyeth. (2004). Enbrel TV Ad. Cited July 11, 2013. http://www.youtube.com/watch?v=7JLN_QR6Wl8.
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J. K. (2005). Neurobiological mechanisms of the placebo effect. Journal of Neuroscience, 25(45), 10390–10402.
Biegler, P., & Vargas, P. (2013). Ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising. American Journal of Bioethics, 13(5), 3–13.
Bizer, G. Y., Barden, J. C., & Petty, R. E. (2003). Attitudes. In L. Nadel (Ed.), Encyclopedia of cognitive science. Hampshire: MacMillan.
Bok, S. (1974). The ethics of giving placebos. Scientific American, 231(5), 17–23.
Brunstrom, J. M., & Higgs, S. (2002). Exploring evaluative conditioning using a working memory task. Learning and Motivation, 33, 433–455.
Buss, S. (2008). Personal autonomy. The Metaphysics Research Lab, Stanford University. Cited July 11, 2013. http://plato.stanford.edu/entries/personal-autonomy/.
Colloca, L., & Benedetti, F. (2005). Placebos and painkillers: Is mind as real as matter? Nature Reviews Neuroscience, 6(7), 545–552.
De Houwer, J. (2009). Conditioning as a source of liking: There is nothing simple about it. In M. Wanke (Ed.), Social psychology of consumer behavior. New York: Taylor and Francis.
De Houwer, J. (2011). Evaluative conditioning: A review of functional knowledge and mental process theories. In T. R. Schachtman & S. S. Reilly (Eds.), Associative learning and conditioning theory: Human and non-human applications. Oxford: Oxford University Press.
De Houwer, J., Baeyens, F., & Eelen, P. (1994). Verbal evaluative conditioning with undetected US presentations. Behaviour Research and Therapy, 32(6), 629–633.
Eagly, A. H., & Chaiken, S. (1993). The psychology of attitudes. Fort Worth, TX: Harcourt Brace Jovanovich College Publishers.
Eifert, G. H., Craill, L., Carey, E., & O’Connor, C. (1988). Affect modification through evaluative conditioning with music. Behaviour Research and Therapy, 26(4), 321–330.
Faden, R. R., Beauchamp, T. L., & King, N. M. P. (1986). A history and theory of informed consent. New York: Oxford University Press.
Foddy, B. (2009). A duty to deceive: Placebos in clinical practice. American Journal of Bioethics, 9(12), 4–12.
Foley, R. (2008). An epistemology that matters. In P. J. Weithman (Ed.), Liberal faith: Essays in honor of Philip Quinn. Notre Dame, IN: University of Notre Dame Press.
Food and Drug Administration. (2001). Guidance for industry: E 10 Choice of control group and related issues in clinical trials. Rockville.
Giang, D. W., Goodman, A. D., Schiffer, R. B., Mattson, D. H., Petrie, M., Cohen, N., et al. (1996). Conditioning of cyclophosphamide-induced leukopenia in humans. The Journal of Neuropsychiatry and Clinical Neurosciences, 8(2), 194–201.
Gibson, B. (2008). Can evaluative conditioning change attitudes toward mature brands? New evidence from the implicit association test. Journal of Consumer Research, 35, 178–188.
Hahn, R. A. (1997). The nocebo phenomenon: Concept, evidence, and implications for public health. Preventive Medicine, 26(5), 607–611.
Hofmann, W., De Houwer, J., Perugini, M., Baeyens, F., & Crombez, G. (2010). Evaluative conditioning in humans: A meta-analysis. Psychological Bulletin, 136(3), 390–421.
Hrobjartsson, A., & Gotzsche, P. C. (2001). Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine, 344(21), 1594–1602.
Jordan, J. (1996). Pragmatic arguments and belief. American Philosophical Quarterly, 33(4), 409–420.
Kawall, J. (2010). Autonomy, agency, and the value of enduring beliefs. Canadian Journal of Philosophy, 40(1), 107–129.
Kirsch, I. (1985). Response expectancy as a determinant of experience and behavior. American Psychologist, 40(11), 1189–1202.
Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention and Treatment, 1(1), 1–16.
Krosnick, J. A., Jussim, L. J., & Lynn, A. R. (1992). Subliminal conditioning of attitudes. Personality and Social Psychology Bulletin, 18(2), 152–162.
Lang, P. J., Bradley, M. M., & Cuthbert, B. N. (2008). International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Technical Report A-8. Gainesville, FL: University of Florida.
Pavlov, I. (1927). Conditioned reflexes: An investigation of the physiological activity of the cerebral cortex (G. V. Anrep, Trans.). London: Oxford University Press.
Pfizer. Lipitor commercial. Cited July 11, 2013. http://www.youtube.com/watch?v=lNFuEcy5ekg.
Price, D. D., Finniss, D. G., & Benedetti, F. (2008). A comprehensive review of the placebo effect: Recent advances and current thought. Annual Review of Psychology, 59, 565–590.
Price, D. D., Milling, L. S., Kirsch, I., Duff, A., Montgomery, G. H., & Nicholls, S. S. (1999). An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain, 83(2), 147–156.
Reisner, A. (2008). Weighing pragmatic and evidential reasons for belief. Philosophical Studies, 138, 17–27.
The Hastings Center. (1996). The goals of medicine. Setting new priorities. The Hastings Center Report, 26(6), S1–S27.
Rogers v Whitaker. (1992). 67 Australian Law Journal Reports 47.
Roullet, B., & Droulers, O. (2005). Pharmaceutical packaging colour and drug expectancy. Advances in Consumer Research, 32, 164–171.
Rozin, P., Wrzesniewski, A., & Byrnes, D. (1998). The elusiveness of evaluative conditioning. Learning and Motivation, 29, 397–415.
Schneiderman, L. J., Jecker, N. S., & Jonsen, A. R. (1990). Medical futility: Its meaning and ethical implications. Annals of Internal Medicine, 112(12), 949–954.
Shiv, B., Carmon, Z., & Ariely, D. (2005a). Ruminating about placebo effects of marketing actions. Journal of Marketing Research, 42, 410–414.
Shiv, B., Carmon, Z., & Ariely, D. (2005b). Placebo effects of marketing actions: Consumers may get what they pay for. Journal of Marketing Research, 42, 383–393.
Silberman, S. (2009). Placebos are getting more effective. Drugmakers are desperate to know why. Cited July 11, 2013. http://www.wired.com/medtech/drugs/magazine/17-09/ff_placebo_effect?currentPage=all.
Skene, L., & Smallwood, R. (2002). Informed consent: Lessons from Australia. British Medical Journal, 324(7328), 39–41.
Stewart-Williams, S., & Podd, J. (2004). The placebo effect: Dissolving the expectancy versus conditioning debate. Psychological Bulletin, 130(2), 324–340.
Sweldens, S., Van Osselaer, S. M. J., & Janiszewski, C. (2010). Evaluative conditioning procedures and the resilience of conditioned brand attitudes. Journal of Consumer Research, 37(October), 473–489.
Swinburne, R. (2001). Epistemic justification. New York: Oxford University Press.
Tilburt, J. C., Emanuel, E. J., Kaptchuk, T. J., Curlin, F. A., & Miller, F. G. (2008). Prescribing “placebo treatments”: Results of national survey of US internists and rheumatologists. British Medical Journal, 337, a1938.
Vase, L., Robinson, M. E., Verne, G. N., & Price, D. D. (2003). The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain, 105(1–2), 17–25.
Waber, R. L., Shiv, B., Carmon, Z., & Ariely, D. (2008). Commercial features of placebo and therapeutic efficacy. Journal of the American Medical Association, 299(9), 1016–1017.
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002). Placebo response in studies of major depression: Variable, substantial, and growing. JAMA, 287(14), 1840–1847.
Walther, E. (2002). Guilty by mere association: Evaluative conditioning and the spreading attitude effect. Journal of Personality and Social Psychology, 82(6), 919–934.
Young, R. (1982). The value of autonomy. The Philosophical Quarterly, 32(126), 35–44.
About this article
Cite this article
Biegler, P. Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising. J Bus Ethics 123, 145–155 (2014). https://doi.org/10.1007/s10551-013-1805-0